Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Ampersand Biomedicines Inc.

Headquarters: Boston, MA, United States of America
Year Founded: 2021
Status: Private

BioCentury | Mar 21, 2025
Finance

Maxion, Ampersand, Latigo, Arbor raise private rounds: Finance Report

Plus: SV Health Investors hits $250M goal for second Dementia Discovery Fund
BioCentury | Nov 26, 2024
Deals

Kyowa Kirin brings global reach to Kura’s menin program via licensing deal

Also in BioCentury’s Deals Report: Novartis buys gene therapy play Kate, Telix buys FAP-targeting theranostics, and more
BioCentury | Jan 6, 2024
Product Development

Flagship’s AI hub: making models that co-pioneer

The VC’s Pioneering Intelligence unit is experimenting with new methods, operationalizing tools, and creating companies
BioCentury | Aug 14, 2023
Management Tracks

Gardner named CEO of Flagship’s Ampersand

Plus: Brian Powl joins Kura as CCO, and updates from BioNTech, Allogene, CG and more
BioCentury | Mar 7, 2023
Finance

Ampersand, Rapport launches reflect precision medicine trend

Plus: Noema and LENZ raise oversubscribed series B rounds
Items per page:
1 - 5 of 5